Dublin, Oct. 18, 2017 -- The "Global Body Composition Analyzers Market - Trends and Forecast to 2024" report has been added to Research and Markets' offering.
Synopsis:
- Global Body Composition Analyzers Market is expected to reach USD 1,790.50 million by 2024, at a CAGR of 7.6% during the forecast period of 2017 to 2024. The report contains 215 pages of exclusive premium insights with 87 tables and 65 figures.
- Global Body Composition Analyzers Market is segmented based on product type, end-users and geography.
- On the basis of route of administration the market is segmented into Bio impedance Analyzers (BIA), Dual-Energy X-Ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement Plethysmography (ADP), and others (Hydrostatic Weighing (HwD), Ultrasound Body Composition
- On the basis of end users the market is segmented into Health Clubs, Hospitals and Clinics, Corporate Settings, and others (Medical Research, Universities).
- The global body composition analyzers market is segmented into 5 regions such as North America, Europe, Asia-Pacific, South America and Middle East and Africa.
Major Players Operating in this Market: Tanita (Japan), InBody CO., LTD. (South Korea), along with others are, Omron Healthcare, Inc. (Japan), Selvashealthcare (Korea), Bodystat (U.K.), Hologic, Inc. (U.S.), GE Healthcare (U.K.), COSMED (Italy), Beurer GmbH (Germany), seca (Germany), RJL SYSTEMS (U.S.A), Maltron International Ltd. (U.K.), LaicaSpA (Italy) among others.
Key Topics Covered:
1. Introduction
2. Market Segmentation
3. Research Methodology
4. Market Overview
4.1. Drivers
4.1.1. Aging Population Globally
4.1.2. Rising Obesity Globally
4.1.3. Government Initiatives
4.1.4. Key Players are Taking Strategic Decisions to Gain Market Share
4.1.5. Increasing Diseases Due to Changing Lifestyle
4.2. Restraints
4.2.1. Regulatory Framework
4.2.2. High Cost of Equipment
4.3. Opportunities
4.3.1. Rising Fitness Industry
4.3.2. Growing Number of Weight Loss Clinics
4.4. Challenges
4.4.1. Requirement of Trained Staff
4.4.2. Inconsistent Results
5. Premium Insights
6. Executive Summary
7. Global Body Composition Analyzers Market, by Product Type
7.1. Overview
7.2. Bio Impedance Analyzers (Bia)
7.3. Skinfold Caliper
7.4. Dual Energy X-Ray Absorptiometry (Dexa)
7.5. Air Displacement Plethysmography (Adp)
7.6. Others
8. Global Body Composition Analyzers Market, by End User
8.1. Overview
8.2. Hospitals and Clinics
8.3. Corporate Settings
8.4. Health Clubs
8.5. Other End Users
9. Global Body Composition Analyzers Market, by Country
10. Global Body Composition Analyzers Market
11. Company Profiles
- Omron Healthcare Inc. (Japan)
- Selvashealthcare (Korea)
- Bodystat (U.K.)
- Hologic Inc. (U.S.)
- GE Healthcare (U.K.)
- COSMED (Italy)
- Beurer GmbH (Germany)
- seca (Germany)
- RJL SYSTEMS (U.S.A)
- Maltron International Ltd. (U.K.)
- LaicaSpA (Italy)
For more information about this report visit https://www.researchandmarkets.com/research/s4gqkf/global_body
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices


Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 



